Dyve and Moffitt collaborate to study buffering agent for transdermal delivery in cancer models Feb. 7, 2022
Mindset to initiate proof-of-concept preclinical studies on Family 3 compounds for cognitive benefit Feb. 7, 2022
Parkinson's UK and Domainex collaborate to target neuroinflammation to slow Parkinson's disease Feb. 7, 2022
eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination Feb. 7, 2022
RSS